Biotech Stock Plunges on Bitcoin Plans as Ethereum Treasuries Stay Hot
Lixte Biotechnology's share price fell hard after it revealed a Bitcoin treasury, while firms stashing Ethereum have been surging of late.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This ethereum story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
A staked Ethereum ETF processed $48M in redemptions while keeping 86% of ETH locked, 21Shares filing shows
The 21Shares Ethereum ETF, which trades as TETH, reported $48.4 million in TETH redemptions during the first half of 2026 and ende...
xStocks dominates tokenized stock deposits into DeFi with 58% share
xStocks' dominance in tokenized stocks within DeFi could centralize influence, impacting market dynamics and innovation in decentr...
Bitcoin’s ETF rebound just lost 38% of its gains in four sessions as BTC fell below $63,000
Morgan Stanley’s Bitcoin Trust and Grayscale’s Bitcoin Mini Trust ETF were the only US spot Bitcoin funds to attract capital on Au...
Norway Holds $400M in Bitcoin via Indirect Stock Exposure
Key Takeaways: Norway’s Government Pension Fund Global holds about $400 million in ind.rect BTC and ETH The fund does not directly...
Institutional investor Paul Tudor Jones adds 109,446 BlackRock Bitcoin ETF shares while cutting calls by 85%
Tudor Investment reported 18.9% more direct shares in BlackRock's iShares Bitcoin Trust ETF at June 30 than it held three months e...
SharpLink Will Stake $200M of Ethereum Through Lido's wstETH
Sharplink plans to stake roughly 12% of its total Ethereum holdings through Lido, earning yield while staying active in DeFi.